Effect of KMD-3213, an alpha 1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta

European Journal of Pharmacology
R YamagishiM Kitazawa

Abstract

KMD-3213, (-)-(R)-1-(3-hydroxypropyl)-5-[2-[[2-[2-(2,2,2-trifluoroethoxy) phenoxy]ethyl]amino]propyl]indoline-7-carboxamide, a newly synthesized alpha 1-adrenoceptor antagonist, has been shown to have potent action toward, and to be selective for human cloned and native alpha 1-adrenoceptors. In the present study, we characterized the inhibitory effect of KMD-3213 on the phenylephrine (alpha 1-adrenoceptor-selective agonist)-induced contraction of rabbit prostate, rabbit thoracic aorta and rat thoracic aorta to functionally confirm the tissue selectivity of KMD-3213. The mean pA2 value for KMD-3213 for the inhibition of the rabbit prostatic contraction was 10.05, whereas the values for the rabbit and rat aortic contractions were 9.36 and 8.13, respectively. The order of mean pA2 values for the inhibition of the rabbit prostatic contraction was KMD-3213 > or = tamsulosin > prazosin, whereas that for the rabbit and rat aortic contractions was tamsulosin > KMD-3213 > prazosin and tamsulosin > or = prazosin > KMD-3213, respectively. KMD-3213 produced a sigmoidal inhibition curve for single-dose phenylephrine-induced contractions of rabbit prostate, whereas it produced a non-sigmoidal curve for that of rabbit aorta. KMD-3213 had no ...Continue Reading

References

Jan 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·K HondaK Shiono
Jan 1, 1994·Current Therapy in Endocrinology and Metabolism·J Geller
Jun 1, 1994·Trends in Pharmacological Sciences·A P FordD E Clarke
May 1, 1994·Clinical and Experimental Pharmacology & Physiology·S YamadaK Kawabe
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD

❮ Previous
Next ❯

Citations

Mar 22, 2001·International Journal of Urology : Official Journal of the Japanese Urological Association·K AkiyamaS Tsuchida
Mar 7, 2006·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Satoshi TatemichiNobuo Shibata
Mar 7, 2006·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Mamoru KobayashiNobuo Shibata
Dec 1, 2010·Drug Design, Development and Therapy·Maxime Rossi, Thierry Roumeguère
Nov 29, 2007·Expert Opinion on Investigational Drugs·Masaki YoshidaKazuki Kawabe
Jul 31, 2007·European Journal of Pharmacology·Yoshitaka TomiyamaYoshinobu Yamazaki
Jul 13, 2011·British Journal of Pharmacology·A NishimuneI Muramatsu
Feb 9, 2006·British Journal of Pharmacology·Martin C Michel, Wim Vrydag
Apr 1, 1997·Expert Opinion on Investigational Drugs·J P Hieble, R R Ruffolo
Jan 5, 2001·Expert Opinion on Investigational Drugs·C Forray, S A Noble
Jan 1, 2013·European Journal of Pharmacology·Takumi SakaiHiroshi Kuriyama
Jan 8, 2017·Rapid Communications in Mass Spectrometry : RCM·Sukanya PandetiThota Jagadeswar Reddy
May 26, 2004·British Journal of Pharmacology·Naoyuki TakiIkunobu Muramatsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.